Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Aminothiophene. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107880015B discloses a novel lithiation-amination route for 3-bromo-2-aminothiophene. High yield, mild conditions, and scalable process for pharmaceutical intermediates.
Novel one-pot synthesis patent CN103980248B offers high-yield antitumor intermediates with mild conditions for reliable pharmaceutical supply chains and cost efficiency.
Patent CN101535290A reveals a protective-group-free hydrogenation method for 2-alkyl-3-aminothiophene derivatives, offering significant cost reduction and scalable manufacturing for agrochemical intermediates.
Novel 3-step route for kinase inhibitor intermediates eliminates high-pressure CO. Enhances safety and scalability for reliable pharmaceutical supply chains.
Patent CN118344336A reveals a one-step catalytic route for high-purity thiophene derivatives, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN116023359B reveals mild catalytic route for aminothiophene intermediates ensuring high purity and scalable supply chain reliability for global pharmaceutical manufacturing.
Patent CN116023359A reveals a breakthrough copper-catalyzed amination route for aminothiophenes, offering superior yields and safety over traditional nitration for pharmaceutical supply chains.
Patent CN109867658B enables efficient production of diverse aminothiophene derivatives through mild phase transfer catalysis, offering significant cost reduction and enhanced supply chain reliability for pharmaceutical manufacturing.